| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.96B | 20.93B | 25.07B | 32.54B | 20.52B | 16.64B |
| Gross Profit | 6.70B | 8.16B | 9.35B | 9.15B | 5.16B | 5.07B |
| EBITDA | 5.28B | 5.42B | 3.49B | 5.40B | 3.60B | 3.34B |
| Net Income | 2.31B | 1.89B | 742.00M | 2.54B | 1.44B | 1.39B |
Balance Sheet | ||||||
| Total Assets | 43.56B | 37.34B | 41.28B | 49.96B | 39.97B | 32.06B |
| Cash, Cash Equivalents and Short-Term Investments | 230.30M | 1.81B | 2.11B | 7.14B | 1.58B | 1.58B |
| Total Debt | 12.59B | 10.49B | 13.73B | 18.49B | 10.38B | 4.26B |
| Total Liabilities | 32.01B | 28.29B | 34.08B | 44.20B | 34.42B | 24.60B |
| Stockholders Equity | 10.18B | 8.11B | 7.02B | 5.56B | 5.38B | 7.32B |
Cash Flow | ||||||
| Free Cash Flow | 2.81B | 1.72B | 2.41B | -460.00M | 539.00M | 1.25B |
| Operating Cash Flow | 4.73B | 3.57B | 4.70B | 1.67B | 2.62B | 2.95B |
| Investing Cash Flow | -2.84B | -1.33B | 3.20B | -8.16B | -3.07B | -1.73B |
| Financing Cash Flow | -4.04B | -3.50B | -6.66B | 6.65B | 752.00M | -1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $38.24B | 15.63 | 25.93% | 4.06% | -0.86% | 106.28% | |
70 Outperform | $61.92B | 17.11 | 12.85% | 3.25% | 7.66% | 37.42% | |
70 Outperform | $90.83B | 18.36 | 9.92% | 3.61% | 4.80% | 14.44% | |
70 Outperform | $165.55B | 25.37 | 12.48% | 2.84% | 26.96% | -6.80% | |
68 Neutral | $96.04B | 21.63 | 13.06% | 3.40% | 9.40% | -6.05% | |
66 Neutral | $25.65B | 23.54 | 7.65% | 3.13% | 8.42% | 32.48% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% |